The outbreak of mycoplasma bacteria is expected to propel the growth of the mycoplasma diagnostics market. In March 2021, Jackson Hole valley of Teton County, Wyoming, United States, reported outbreaks of mycoplasma bacteria spreading through dogs. Moreover, increasing the diagnosis of mycoplasma is also expected to aid in the growth of the mycoplasma diagnostics market. In November 2020, the Ministry for Primary Industries, New Zealand, stated that cattle herds on two Southland farms were being tested to determine whether they are infected with Mycoplasma Bovis.
High demand for beef is expected to offer lucrative growth opportunities for players in the mycoplasma diagnostics market. According to the USDA National Agricultural Statistics Service (NASS), in November 2019, beef exports from the U.S. totaled 245 million pounds.
The mycoplasma diagnostics market in the Asia Pacific is witnessing the high cost of the mycoplasma bovis eradication program. In September 2019, The Ministry for Primary Industries, New Zealand, reported that the mycoplasma bovis eradication program cost more than US$ 203 million to date - excluding compensation to farmers. Moreover, significant growth in the dairy sector is also expected to aid in the growth of the mycoplasma diagnostics market. According to National Dairy Development Board, India, milk production in India increased from 178.3 million tons in 2017-18 to 187.7 million tons in 2018-19.
In May 2021, Microbix Biosystems Inc., a life sciences innovator and exporter, appointed SDT Molecular Pte Ltd as distributor of Microbix's quality assessment products for four Asia Pacific territories. The products include SARS-CoV-2 molecular-test and antigen-test quality assessment products along with quality assessment products for support of the accuracy of testing for Human Papilloma Virus and Mycoplasma genitalium.
The mycoplasma diagnostics market in North America is driven by an increasing number of households with companion animals. According to the 2017-2018 U.S. Pet Ownership & Demographics Sourcebook of American Veterinary Medical Foundation (AVMF), 38.4% of households in the U.S. owned dogs compared to 36.5% in 2012.
Major players in the mycoplasma diagnostics market are focused on the approval and launch of new products to expand their product portfolio. In January 2019, Hologic, Inc. received the U.S. Food and Drug Administration (FDA) clearance for its Aptima Mycoplasma genitalium assay, the first and only FDA-cleared test to detect under-recognized but increasingly common sexually transmitted infection.
Major players in the market are also focused on adopting various strategies to enhance their market share. In September 2020, Zoetis released an update of the comprehensive manual, "A Contemporary Review of Mycoplasma hyopneumoniae Control Strategies," a 62-page booklet with 14 articles developed by swine disease experts specializing in this pathogen.